Lung squamous cell carcinoma with severe hypomagnesemia due to cisplatin plus gemcitabine in combination with necitumumab therapy: A case report

A 72‐year‐old man, diagnosed with advanced lung squamous cell carcinoma, was administered of cisplatin plus gemcitabine with necitumumab, a human monoclonal antibody that binds to the epidermal growth factor receptor (EGFR), as a sixth‐line treatment. Tumor shrinkage was observed, but asymptomatic g...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakao, Akira, Inoue, Hiroyuki, Osaki, Yusuke, Hirano, Ryosuke, Harada, Taishi, Aoyama, Takashi, Igata, Fumiyasu, Fujita, Masaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2021
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8258358/
https://www.ncbi.nlm.nih.gov/pubmed/34061460
http://dx.doi.org/10.1111/1759-7714.13999

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8258358/
https://www.ncbi.nlm.nih.gov/pubmed/34061460
http://dx.doi.org/10.1111/1759-7714.13999

Ejemplares similares